Europe · Wires & real time · ANP

LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization

Published by ANP · Netherlands 18 h ago

- LIPSIA-STRATEGY evaluated whether revascularization guided by angiography-based FFR using CAAS vFFR (vessel Fractional Flow Reserve), delivers clinical outcomes comparable to…

Read the full article on ANP Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (persportaal.anp.nl)

Also worth reading

TASS

LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization

Share

Also worth reading

Europeans taking too long to choose negotiator for talks with Russia — Kremlin

Major central banks signal December tightening amid persistent inflation

Trading Day: Oil slump no cure for AI angst

Fastmarkets clarifies China domestic steel scrap methodology guide

Merz says Germany must preserve 'digital sovereignty' in AI era

India markets regulator backs removal of long-term capital gains tax for foreign investors, sources say